Cosmos Health Inc. (COSM) - Dilution Analysis

10-Q filing | 54.4M shares outstanding

S-3/A filing: This S-3/A filing registers for resale 73,523,716 shares of Common Stock issuable upon conversion or otherwise pursuant to the terms of the Notes issued to the Selling Stockholders.

10-K filing | 50.8M shares outstanding

10-Q filing | 34.9M shares outstanding

S-3 filing: Cosmos Health Inc. is offering up to $100,000,000 of shares of common stock through an at-the-market offering via A.G.P. / Alliance Global Partners as sales agent, as detailed in the preliminary prospectus supplement.

S-1/A filing: Cosmos Health Inc. is offering common stock, pre-funded warrants, and common warrants on a reasonable best efforts basis.

10-Q filing | 26.0M shares outstanding

10-K filing | 27.3M shares outstanding

S-1/A filing: This S-1/A filing includes exhibits related to a potential offering, including forms of placement agent agreement, pre-funded warrant, and common warrant.

S-1/A filing: This S-1/A filing from Cosmos Health Inc. relates to a potential offering of common stock and warrants. The company is selling 901,488 shares for $629,426 pursuant to an at-the-market sales agreement and has entered into a Warrant Inducement Letter to issue 9,748,252 new warrants and reduce the exercise price of existing warrants.

S-1/A filing: This S-1/A filing describes the offering of Pre-Funded Warrants and Common Warrants to purchase common stock.

S-1/A filing: This S-1/A filing describes the terms of Pre-Funded Warrants and Common Warrants being offered, including exercise price, duration, exercisability, cashless exercise, transferability, and rights as a shareholder.

S-1 filing: This S-1 filing describes the terms of Pre-Funded Warrants and Common Warrants being offered.

S-1/A filing: This prospectus relates to the resale by Armistice Capital Master Fund, Ltd. of up to 9,748,252 shares of Common Stock of Cosmos Health Inc. issuable upon exercise of warrants.

S-1/A filing: This prospectus relates to the resale by Armistice Capital Master Fund, Ltd. of up to 9,748,252 shares of Common Stock issuable upon exercise of warrants to purchase shares of Common Stock.

S-1/A filing: This prospectus relates to the resale by Armistice Capital Master Fund, Ltd. of up to 9,748,252 shares of Common Stock issuable upon exercise of warrants to purchase shares of Common Stock.

10-Q filing | 23.3M shares outstanding

S-1 filing: This S-1 filing relates to the issuance and resale of up to 9,748,252 shares of common stock issuable upon exercise of warrants to Armistice Capital Master Fund, Ltd.

8-K filing: Cosmos Health Inc. entered into an agreement with a warrant holder to issue new warrants in exchange for the exercise of existing warrants, with the holder paying a reduced exercise price of $0.8701 per share.

POS AM filing: This prospectus relates to the issuance by us of up to 6,936,996 shares of common stock, par value $.001 per share of Cosmos Health Inc.

POS AM filing: This prospectus relates to the issuance by us of up to 6,936,996 shares of common stock, par value $.001 per share, consisting of (i) up to 2,045,710 shares issuable upon the exercise of December 2022 Warrants, (ii) up to 20,162 shares issuable upon the exercise of July 2023 Warrants, and (iii) up to 4,874,124 shares issuable to Armistice Capital Master Fund Ltd. upon the exercise of the Armistice New Warrants.

POS AM filing: This prospectus relates to the issuance by us of up to 6,936,996 shares of common stock issuable upon the exercise of December 2022 Warrants, July 2023 Warrants and Armistice New Warrants, and also relates to the resale by the selling securityholders of the shares of Common Stock issuable to the Selling Securityholders upon exercise of the Warrants.

POS AM filing: This prospectus relates to the issuance by Cosmos Health Inc. of up to 6,936,996 shares of common stock issuable upon the exercise of certain warrants and the resale of shares of common stock issuable to the selling securityholders upon exercise of the warrants.

10-Q filing | 17.0M shares outstanding

10-Q filing | 16.9M shares outstanding

10-K filing | 17.6M shares outstanding

S-3 filing: This S-3 filing relates to the potential resale of common stock issuable upon exercise of warrants held by Armistice Capital LLC.

8-K filing: Cosmos Health Inc. entered into a warrant exchange agreement with one holder to exchange existing warrants for new warrants to purchase up to 4,874,126 shares of common stock at an exercise price of $1.45 per share, with A.G.P. Alliance Global Partners acting as financial advisor.

10-Q filing | 13.4M shares outstanding

S-3 filing: This S-3 filing registers for resale 1,935,485 shares of common stock issuable upon exercise of warrants, with the company potentially receiving gross proceeds of up to $5,322,581 from the full exercise of these warrants for working capital and general corporate purposes.

10-Q filing | 10.6M shares outstanding

8-K filing: Cosmos Health Inc. closed a registered direct offering and concurrent private placement on July 21, 2023, issuing 2,116,936 shares of common stock, 715,323 pre-funded warrants, and common warrants to purchase 1,935,484 shares, generating gross proceeds of $5,250,000. ($15.75M proceeds)

10-Q filing | 10.6M shares outstanding

8-K filing: Cosmos Health Inc. entered into a Stock Purchase Agreement to acquire 100% of Pharmaceutical Laboratories Cana S.A. (Cana Holdings) for €800,000 and 46,377 shares of Cosmos restricted common stock at $17.25 per share. ($0.8M proceeds)

10-K filing | 10.6M shares outstanding

S-3 filing: This S-3 filing registers for resale 2,567,450 shares of common stock issuable upon exercise of warrants, with an exercise price of $11.50 per share and expiring on December 21, 2022. The company may receive gross proceeds of up to $29,525,675 from the full exercise of the Warrants.

8-K filing: Cosmos Health Inc. entered into an amendment to the Securities Purchase Agreement with its Chief Executive Officer, Grigorios Siokas, regarding the purchase of securities in the December 19, 2022 Registered Direct Offering, where Mr. Siokas forfeited the warrants received in the offering. ($6.0M proceeds)

8-K filing: Cosmos Health Inc. entered into a Securities Purchase Agreement for a registered direct offering and a concurrent private placement, issuing 2,828,320 shares of Common Stock and warrants to purchase 2,828,320 shares at a unit price of $11.50, with gross proceeds of approximately $32.5 million before fees. ($32.53M proceeds)

8-K filing: Stock split 1-for-25 | Outstanding: 83,797,481 → 3,351,899

S-3/A filing: Cosmos Holdings Inc. may offer and sell common stock, preferred stock, and warrants/units for an aggregate initial offering price of $50,000,000.

10-Q filing | 83.8M shares outstanding

S-3/A filing: Cosmos Holdings Inc. may offer and sell common stock, preferred stock, warrants/units, and subscription rights from time to time in one or more offerings at prices and on terms that we will determine at the time of each offering, for an aggregate initial offering price of $50,000,000.

8-K filing: Cosmos Holdings Inc. entered into a Securities Purchase Agreement to sell $7,500,000 of securities, consisting of 62,500,000 shares of common stock, pre-funded warrants, and warrants to purchase 125,000,000 shares of common stock in a public offering. ($7.5M proceeds)

S-1/A filing: The company issued Series A Convertible Preferred Stock and warrants to purchase common stock for aggregate gross proceeds of approximately $6 million.

S-1/A filing: The filing registers an indeterminate number of common stock, preferred stock, warrants, and units with an aggregate initial offering price not to exceed $7,000,000.

S-1/A filing: This S-1/A filing outlines a proposed offering of common stock and warrants by Cosmos Holdings Inc., with A.G.P./Alliance Global Partners acting as the sole placement agent, aiming to raise between $12.0 and $15.0 million for working capital and corporate purposes.

8-K filing: Cosmos Holdings Inc. entered into a Warrant Exchange Agreement to exchange existing warrants for new warrants to purchase twice the number of shares of common stock, with the new warrants exercisable at $0.205 per share, and the company will pay each holder $500,000 and grant a 30% participation right in future equity offerings.

S-3 filing: This is an S-3 filing for a potential at-the-market offering of common stock, as well as information regarding Series A Convertible Preferred Stock and warrants issued in a private placement.

S-1 filing: Cosmos Holdings Inc. is offering up to $12 million of common stock, pre-funded warrants, and common warrants in a best efforts offering.

10-Q filing | 26.0M shares outstanding

S-1/A filing: Registration of up to 44,914,285 shares of the Company's common stock, par value $0.001 per share.

S-1 filing: This is an S-1 filing which includes information on convertible debt, stock option plans, and director compensation.

10-Q filing | 17.8M shares outstanding

10-K filing | 16.4M shares outstanding

8-K filing: On October 29, 2020, the company issued 259,741 shares of common stock at $3.85 per share in exchange for the reduction of $1,000,000 on the principal amount of a note.

10-Q filing | 17.1M shares outstanding

8-K filing: The company amended and restated its articles of incorporation and filed a certificate of designation for its Series A Preferred Stock, authorizing the issuance of preferred stock and defining its conversion terms into common stock. Additionally, the company entered into a securities purchase agreement to issue 5,000,000 shares of Series A Preferred Stock for $5,000,000. ($5.0M proceeds)

8-K filing: The Company entered into a securities purchase agreement to issue 5,000,000 shares of Series A Preferred Stock for $5,000,000 and issued a convertible promissory note in the principal amount of $525,000 for a purchase price of $500,000. Several notes were also converted into shares of the Company's Common Stock during July and August of 2021. ($5.0M proceeds)

10-Q filing | 16.1M shares outstanding

8-K filing: Cosmos Holdings, Inc. issued 321,500 shares of common stock at $5.00 per share in exchange for €1,350,000 of debt and agreed to issue 238,000 shares at $5.00 per share (or market value if higher) upon Nasdaq approval in exchange for €1,000,000 of debt. ($1.61M proceeds)

8-K filing: Cosmos Holdings Inc. entered into a Debt Exchange Agreement with its CEO, Grigorios Siokas, involving the issuance of 208,333 shares of common stock at $6.00 per share in exchange for $1,250,000 of existing loans. ($1.25M proceeds)

8-K filing: Cosmos Holdings Inc. issued 166,667 shares of common stock to its CEO, Grigorios Siokas, at $6.00 per share in exchange for $1,000,000 of existing loans. ($1.0M proceeds)

8-K filing: Cosmos Holdings Inc. entered into a Debt Exchange Agreement with its CEO, Grigorios Siokas, involving the issuance of 500,000 shares of common stock at $6.00 per share in exchange for $3,000,000 of existing loans. ($3.0M proceeds)

10-Q filing | 15.0M shares outstanding

10-K filing | 16.1M shares outstanding

8-K filing: Cosmos Holdings Inc. entered into a Consulting Agreement where they agreed to pay a consultant 1,800,000 restricted shares of Common Stock at the rate of 200,000 shares per month.

8-K filing: Cosmos Holdings Inc. issued 781,819 shares of common stock at $3.85 per share in exchange for $3,010,000 of existing loans. ($3.01M proceeds)

8-K filing: Cosmos Holdings Inc. entered into a Debt Exchange Agreement to issue 259,741 shares of common stock at $3.85 per share in exchange for $1,000,000 of existing debt. ($1.0M proceeds)

8-K filing: Cosmos Holdings Inc. entered into a Debt Exchange Agreement to issue 781,819 shares of common stock at $3.85 per share in exchange for $3,010,000 of existing loans. ($3.01M proceeds)

10-Q filing | 13.2M shares outstanding

10-Q filing | 13.2M shares outstanding

10-Q filing | 13.2M shares outstanding

10-K filing | 13.3M shares outstanding